IBB icon

iShares Biotechnology ETF

463 hedge funds and large institutions have $4.63B invested in iShares Biotechnology ETF in 2016 Q3 according to their latest regulatory filings, with 87 funds opening new positions, 146 increasing their positions, 137 reducing their positions, and 44 closing their positions.

Holders
463
Holders Change
+35
Holders Change %
+8.18%
% of All Funds
12.37%
Holding in Top 10
25
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+25%
% of All Funds
0.67%
New
87
Increased
146
Reduced
137
Closed
44
Calls
$650M
Puts
$1.24B
Net Calls
-$586M
Net Calls Change
+$176M
Name Market Value Shares Shares
Change
Shares
Change %
FMA
501
FNY Managed Accounts
New York
-100 Closed
MMG
502
Monetary Management Group
Missouri
-75 Closed
FFC
503
First Financial Corp
Indiana
-55 Closed
JWA
504
JFS Wealth Advisors
Pennsylvania
-40 Closed
RFWA
505
RPg Family Wealth Advisory
Massachusetts
-39 Closed
CFG
506
CKW Financial Group
Hawaii
-7 Closed
NCM
507
Nelson Capital Management
California
-3 Closed
ECM
508
Exchange Capital Management
Michigan
-1 Closed
ST
509
Spot Trading
Illinois
USAA
510
United Services Automobile Association
Texas
HCMT
511
Highland Capital Management (Texas)
Texas
HT
512
HAP Trading
New York
PC
513
Passport Capital
California
GTC
514
Ghost Tree Capital
New York
CWM
515
CIBC World Markets
New York
AC
516
Argentiere Capital
Switzerland
Jennison Associates
517
Jennison Associates
New York
Parallax Volatility Advisers
518
Parallax Volatility Advisers
California
$0 1
SCM
519
Scopia Capital Management
New York
Susquehanna International Group
520
Susquehanna International Group
Pennsylvania
ID
521
Integral Derivatives
New York
KPF
522
K2 Principal Fund
Ontario, Canada